24/7 Customer Support
The Korea Bioimpedance Sensor Market is estimated to witness a rise in revenue from US$ 187.8 Mn in 2021 to US$ 288.4 Mn by 2027. The market is registering a CAGR of 7.4% during the forecast period 2022-2027. In terms of volume, the market is anticipated to register a CAGR of 6.4% over the forecast period.
Bioimpedance devices are non-invasive, low-cost, portable, and user-friendly, and are used for the detection of edema, diagnosis of skin-related diseases, detection of cancerous tissues, brain and pulmonary function monitoring and impedance cardiography, and pneumography. Bioimpedance sensors technology is becoming the basis of novel and noninvasive medical diagnostic devices. On a smaller scale, it is used for measuring, analyzing, and imaging individual cells, cell cultures, and suspensions, as well as in electroporation studies. Moreover, bio-impedance sensors require higher power than most other bio-signal acquisition systems due to the need for high-frequency current and voltage management.
Bioimpedance has the potential to play an important role in wearable devices, because of its relative reliability, electrode-based sensing principle, and its broad range of applications. In addition, bioimpedance techniques are also the foundation of various laboratory instruments for cell culture monitoring and cell mechanical properties research based on population, motility, viability, and others. The rising prevalence of chronic conditions such as diabetes and growing awareness among patients about health is the prime factors that propel the market growth.
The major factor responsible for the growth of the Korea bioimpedance sensor market includes the surging incidence of chronic diseases across the country and increasing advancements in life science and healthcare instrumentation. The rising prevalence of chronic disease and robust growth of the geriatric population with ailments that require quick treatments stimulate the demand for bioimpedance sensors. Bioimpedance is a flexible sensing technology that can be utilized for various clinical and lifestyle applications, including body fluid monitoring, gesture monitoring, and hemodynamic parameter monitoring. Moreover, the availability of high-performance health monitoring devices that are integrated with efficient bioimpedance sensors further boosts the bioimpedance sensor market. Furthermore, high bioimpedance sensor adoption in wearables devices creates a significant growth opportunity for the bioimpedance sensor market.
Advances in electronics and instrumentation technology and novel textile materials and textile-electronic integration techniques encourage the development and implementation of sensor-based garments for wearable biomedical monitoring systems. However, less availability of miniaturized instrumentation, novel models, and algorithms will restrain the growth of the adoption of bioimpedance sensors across the Korea market. Also, the lack of a suitable electrode system for wearable applications is a barrier to the development of portable bioimpedance devices.
The study of the Korea Bioimpedance Sensor Market considers various market determinants, industry value chain analysis, and competitor analysis of the market. The report discusses the analysis of the bioimpedance sensor industry for the period 2017-2027, where the base year is 2021 and the forecast period is 2022-2027. The report provides a detailed analysis of the Korea Bioimpedance Sensor Market across 7 Chapters and 46 pages. The report includes data presentation across 13 tables and 9 statistical figures.
The subsequent section provides details of the market analysis based on different segments such as type, application, and country. The report includes a detailed study of the value chain of the industry. It includes suppliers, manufacturers, distributors, and end-users. The bioimpedance sensor market majorly follows the direct channel of marketing because they directly provide sensors to the customers. The basic channel flow covers the bioimpedance sensor process right from product conception to product development and consumption. The report also covers extensively the key competitors in the market for Korea bioimpedance sensor.
Key Takeaways from the Korea Bioimpedance Sensor Market Report
The key players in the Korea Bioimpedance Sensor Market are Omron Corporate, Maxim Integrated, Texas Instruments Incorporated, Analog Devices, Inc. and Baxter International Inc. among others. Through extensive research, it is found that big players have adopted various competitive strategies such as mergers & acquisitions in order to have a grip of an emerging market. Furthermore, leading companies are expanding their geographical boundaries by acquiring small brands and domestic companies.
Korea Bioimpedance Sensor Market is segmented based on type and application. The industry trends in the bioimpedance sensor market are sub-divided into different categories in order to get a holistic view of the Korea marketplace.
Following are the different segments of the Korea Bioimpedance Sensor Market:
By Type segment of the Korea Bioimpedance Sensor Market is sub-segmented into:
By Application segment of the Korea Bioimpedance Sensor Market is sub-segmented into:
Bioimpedance is a flexible sensing technology that can be utilized for various clinical and lifestyle applications, including body fluid monitoring, gesture monitoring, and hemodynamic parameter monitoring.
Bioimpedance devices is a non-invasive, low-cost, portable, and commonly used approach for body composition measurements and assessment of clinical conditions.
A wearable bioimpedance monitoring system is an electronic device with a bioimpedance sensor that captures the wearer's bioimpedance and is worn close to or on the skin's surface.
The Korea bioimpedance sensor market is estimated to expand at a CAGR of 7.4% during the forecast period.
The Korea bioimpedance sensor market was valued at US$ 187.8 Million in 2021.
From hardware integration to model creation, bioimpedance sensing in wearable devices provides a lucrative growth opportunity in the Korea bioimpedance sensor market.
Factors such as surging incidence of chronic diseases across the country and increasing advancements in life science and healthcare instrumentation boost the Korea bioimpedance sensor market during the forecast period.
The non-contact segment is projected to account for 8.0% of the bioimpedance devices market share over the forecast period.
Less availability of miniaturized instrumentation, novel models, and algorithms is a restraining factor that inhibits the growth of the market during the forecast period.
The personal fitness tracking segment is expected to project the highest CAGR over the forecast period in the Korea bioimpedance sensor market.
Type and application are the different segments of the Korea bioimpedance sensor market.
Growing integration of advanced and innovative technology, coupled with rising product launches, provides emerging trends in Korea bioimpedance sensor market.
The key players operating in the market include OMRON Corporate, Maxim Integrated, Texas Instruments Incorporated, Analog Devices, Inc., and Baxter International Inc. among others.